Qiming granules regulate Müller cell pyroptosis and the P2X7R/NLRP3 immune inflammatory pathway in diabetic

Qi Zhou1,2, Min Tang1, Yaping Wang2

  • 1Department of Ophthalmology, The Affiliated Hospital, Southwest Medical University, Luzhou, China.

Chinese Medicine
|March 17, 2026
PubMed
Abstract

Insights

Qiming Granules (QMG) protect against diabetic retinopathy (DR) by inhibiting Müller cell pyroptosis and inflammation via the P2X7R/NLRP3 pathway. Key absorbed components, astragaloside IV and puerarin, demonstrate significant neuroprotective effects.

Area of Science:

  • Ophthalmology and Vision Science
  • Neuroscience
  • Pharmacology

Background:

  • Diabetic retinopathy (DR) involves Müller cell pyroptosis and inflammation, leading to retinal ganglion cell (RGC) damage.
  • Qiming Granules (QMG) are recommended for DR due to their immunomodulatory, antioxidant, and vascular protective properties.

Purpose of the Study:

  • To investigate the protective effects of QMG on early DR neurodegeneration.
  • To elucidate the mechanism of QMG in inhibiting Müller cell pyroptosis and inflammation via the P2X7R/NLRP3 pathway.
  • To identify QMG's absorbed components and evaluate their therapeutic potential.

Main Methods:

  • Established in vivo DR and in vitro high-glucose-induced Müller cell pyroptosis models.
  • Utilized HE staining, electron microscopy, Western blot, ELISA, and immunofluorescence to assess RGC apoptosis, histomorphology, and pyroptosis markers.
  • Employed UPLC-Q-Orbitrap HRMS to identify QMG components in rat plasma and evaluate their effects on Müller cells.

Main Results:

  • QMG significantly inhibited RGC apoptosis and pyroptosis in DR rats by suppressing the P2X7R/NLRP3 pathway.
  • In vitro, QMG reduced Müller cell membrane damage and inflammatory factor release, inhibiting pyroptosis.
  • Nine QMG compounds were absorbed; astragaloside IV and puerarin showed potent inhibition of high glucose-induced Müller cell pyroptosis.

Conclusions:

  • QMG effectively mitigates Müller cell pyroptosis and inflammation, thereby protecting against early DR neurodegeneration.
  • The P2X7R/NLRP3 pathway is a key target for QMG's neuroprotective effects in DR.
  • Astragaloside IV and puerarin are significant pharmacodynamic components of QMG, offering therapeutic potential for DR.